Related Content
- InsightMay 13, 2025
Antitrust & Competition Healthcare Quarterly Update Q1 2025
- Client SpotlightMay 9, 2025
1x1 with Matthew Renfro at Lynx
- Health HeadlinesApril 30, 2025
Health Headlines: April 2025
- AlertApril 24, 2025
Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare
- InsightApril 23, 2025
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
- Client SpotlightApril 10, 2025
1x1 With Dr. Marla Dubinsky at Trellus Health
- Health HeadlinesMarch 28, 2025
Health Headlines: March 2025
- AlertMarch 20, 2025
States Continue to Pursue and Expand Healthcare Market Oversight at an Unprecedented Pace, With Significant Implications for Private Equity
- In the PressMay 19, 2025
Health Data Regulation in Focus As 2025 State Legislative Session Comes to a Close (PLI Plus)
- In the PressMay 1, 2025
AI in Healthcare: Private Equity’s Next Frontier? (Real Deals)
- In the PressApril 8, 2025
Healthcare M&A and Financing in 2025 (HealthcareMarkets)
- Awards and RankingsApril 7, 2025
Goodwin Is Top Law Firm for Global M&A for Q1 2025
- In the PressApril 2, 2025
Goodwin Grows Private Equity Practice With New SF Partner (Law360)
- EventsMarch 27, 2025
Goodwin’s Annual Healthcare & Life Sciences Summit
- Press ReleaseMarch 13, 2025
Goodwin Leads M&A, Private Equity, and Venture Capital League Table Rankings for 2024
- WebinarMarch 11, 2025
PE Implications of Recent Revisions to Massachusetts' Healthcare Transaction Review Law